1Luciano AA. Clinical presentation of hyperprolactinemia. J Reprod Med ,1999 ,44 (12 Suppl) :1085.
2Smith CR, Norman MR. Prolactin and growth hormone: molecular heterogeneity and measurement in serum. Ann Clin Biochem, 1990, 27(4) :542 -550.
3Pinilla I,, Tene - Sempere M, Aguilar R, et al . Effect of N - methyl D- aspartic acid and kainic acid on prolactin secretion in hyper and hypoprolactinaemic conditions . Eur J Endocrinol, 1998,138 ( 4 ) 460 - 466.
4Gregerso KA,Selmanott M. Selective effects of hyperprolactinemia on in vitro dopamine release from median eminence synaptosomes. J Neurosci, 1988,8(7) : 2477 -2484.
5Emiliano AB, Fudge JI. From galactorrhea to osteopenia: rethiuking serotonin - prolaetin interactions. Neuropsychopharmaeology, 2004,29 (5)833 -846.
6Serri O,Chik CL,UR E ,et al. Diagnosis and management of hyperprolactinemia. CM AJ,2003,169 ( 6 ) :575 - 581.
7Cohen A, Davies H. Drμg therapy and hyperprolactinaemia. Adv Drμg Reac Bulle, 1998, JUN :723.
